Product Program year 2025 Source: CMS Open Payments

Liverty

Device Vascular/Oncology

PDI 00382903064663

Open in the dashboard

General payments

$127,384

73 payments

Research payments

$0

0 payments

Through program year 2025, $127,384 in general payments and $0 in research payments were reported against Liverty (Vascular/Oncology).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

3 rows
Year Kind Amount Payments
2025 General $82,000 71
2024 General $34,425 1
2023 General $10,959 1

Breakdown

Who paid General payments · program years 2023–2025
  1. Bard Peripheral Vascular, Inc. $127,097 59 payments
  2. Becton, Dickinson and Company $260 12 payments
  3. Davol Inc. $27 2 payments
Top recipients General payments · program year 2025
  1. Ziv Haskal Vascular & Interventional Radiology · Charlottesville, VA $77,661 95% · 2 payments
  2. Jeffrey Crippin Gastroenterology · Saint Louis, MO $376 <1% · 3 payments
  3. Kaiming Wu Vascular & Interventional Radiology · Houston, TX $276 <1% · 2 payments
  4. Justin Stenz Diagnostic Radiology · Detroit, MI $201 <1% · 2 payments
  5. Joseph Steele Family Medicine · Marquette, MI $183 <1% · 1 payment

The top 5 of 64 recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Vascular & Interventional Radiology Radiology $79,328 97% · 24 practitioners
  2. Diagnostic Radiology Radiology $1,083 1% · 20 practitioners
  3. Gastroenterology Internal Medicine $376 <1% · 1 practitioner
  4. Family Medicine $211 <1% · 2 practitioners
  5. Surgery $201 <1% · 2 practitioners

The top 5 of 15 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. Virginia $77,896 95% · 9 recipients
  2. Michigan $1,184 1% · 11 recipients
  3. Texas $857 1% · 10 recipients
  4. Missouri $417 <1% · 2 recipients
  5. Illinois $192 <1% · 4 recipients

The top 5 of 24 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

73 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record